NCT01614405: Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis |
|
|
| Completed | N/A | 13 | Canada | Truvada and Kaletra, Truvada, Tenofovir, Emtricitabine, Kaletra, lopinavir, ritonavir | University of Alberta, Abbott, Gilead Sciences, Canadian Institutes of Health Research (CIHR) | Primary Biliary Cirrhosis | 07/15 | 08/15 | | |
